Myocardial tumor necrosis factor-alpha secretion in hypertensive and heart failure-prone rats

Am J Physiol. 1999 Aug;277(2):H543-50. doi: 10.1152/ajpheart.1999.277.2.H543.

Abstract

Acute increases in blood pressure (BP) increase myocardial tumor necrosis factor (TNF)-alpha production, but it is not known whether chronic hypertensive stress elevates myocardial TNF-alpha production, possibly contributing to cardiac remodeling, decreased cardiac function, and faster progression to heart failure. BP, cardiac function, and size were evaluated in normotensive [Sprague-Dawley (SD)], spontaneously hypertensive (SHR), and spontaneously hypertensive heart failure-prone (SHHF) rats at 6, 12, 15, and 18 mo of age and in failing SHHF. Left ventricular tissues were evaluated for secretion of bioactive TNF-alpha and inhibition of TNF-alpha secretion by phosphodiesterase inhibitors. All ventricles secreted bioactive and immunoreactive TNF-alpha, but secretion decreased with age. SHR and SHHF rats secreted more TNF-alpha than SD rats at 6 mo of age, but only failing SHHF rats secreted significantly more TNF-alpha at 18 mo. Amrinone inhibited TNF-alpha secretion in all rats and was less potent but more efficacious than RO-201724 in all strains. TNF-alpha secretion correlated with BP and left ventricular mass in 6-mo-old rats, but this relationship disappeared with age. Results suggest that hypertension and/or cardiac remodeling is associated with elevated myocardial TNF-alpha, and, although hypertension, per se, did not maintain elevated cardiac TNF-alpha levels, SHHF rats increase TNF-alpha production during the end stages of failure.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Blood Pressure
  • Body Weight
  • Cardiac Output, Low / genetics*
  • Cardiac Output, Low / metabolism*
  • Cardiac Output, Low / pathology
  • Cardiac Output, Low / physiopathology
  • Genetic Predisposition to Disease*
  • Heart / physiopathology
  • Heart Ventricles
  • Hypertension / metabolism*
  • Hypertension / pathology
  • Hypertension / physiopathology
  • Male
  • Myocardium / metabolism*
  • Myocardium / pathology
  • Organ Size
  • Phosphodiesterase Inhibitors / pharmacology
  • Rats
  • Rats, Inbred SHR / genetics
  • Rats, Sprague-Dawley
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors
  • Tumor Necrosis Factor-alpha / metabolism*

Substances

  • Phosphodiesterase Inhibitors
  • Tumor Necrosis Factor-alpha